Nitric oxide-enhanced Shiga toxin production was regulated by Fur and RecA in enterohemorrhagic Escherichia coli O157. 2017

Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
Departments of Molecular Infectiology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Enterohemorrhagic Escherichia coli (EHEC) produces Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2). Nitric oxide (NO), which acts as an antimicrobial defense molecule, was found to enhance the production of Stx1 and Stx2 in EHEC under anaerobic conditions. Although EHEC O157 has two types of anaerobic NO reductase genes, an intact norV and a deleted norV, in the deleted norV-type EHEC, a high concentration of NO (12-29 μmol/L, maximum steady-state concentration) is required for enhanced Stx1 production and a low concentration of NO (~12 μmol/L, maximum steady-state concentration) is sufficient for enhanced Stx2 production under anaerobic conditions. These results suggested that different concentration thresholds of NO elicit a discrete set of Stx1 and Stx2 production pathways. Moreover, the enhancement of Shiga toxin production in the intact norV-type EHEC required treatment with a higher concentration of NO than was required for enhancement of Shiga toxin production in the deleted norV-type EHEC, suggesting that the specific NorV type plays an important role in the level of enhancement of Shiga toxin production in response to NO. Finally, Fur derepression and RecA activation in EHEC were shown to participate in the NO-enhanced Stx1 and Stx2 production, respectively.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011938 Rec A Recombinases A family of recombinases initially identified in BACTERIA. They catalyze the ATP-driven exchange of DNA strands in GENETIC RECOMBINATION. The product of the reaction consists of a duplex and a displaced single-stranded loop, which has the shape of the letter D and is therefore called a D-loop structure. Rec A Protein,RecA Protein,Recombinases, Rec A
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D000693 Anaerobiosis The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Anaerobic Metabolism,Anaerobic Metabolisms,Anaerobioses,Metabolism, Anaerobic,Metabolisms, Anaerobic
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial
D019453 Escherichia coli O157 A verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. A strain from this serogroup, serotype H7, which produces SHIGA TOXINS, has been linked to human disease outbreaks resulting from contamination of foods by E. coli O157 from bovine origin. E coli O157,E coli O157-H7,Escherichia coli O157-H7
D022621 Shiga Toxin A toxin produced by SHIGELLA DYSENTERIAE. It is the prototype of class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; (RNA, RIBOSOMAL) with PEPTIDE ELONGATION FACTORS. Shigatoxin,Stx Protein, Shigella dysenteria,Shigella Cytotoxin,Shigella Toxin,Stx Protein,Cytotoxin, Shigella,Toxin, Shiga,Toxin, Shigella

Related Publications

Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
June 2007, Proceedings of the National Academy of Sciences of the United States of America,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
December 2007, Applied and environmental microbiology,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
January 2016, Oxidative medicine and cellular longevity,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
June 2006, Proceedings of the National Academy of Sciences of the United States of America,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
February 2009, Infection and immunity,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
June 2006, Journal of clinical microbiology,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
March 2001, Infection and immunity,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
November 2010, Microbial pathogenesis,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
January 2008, Applied and environmental microbiology,
Kimitoshi Ichimura, and Takeshi Shimizu, and Akio Matsumoto, and Shinichiro Hirai, and Eiji Yokoyama, and Hiroki Takeuchi, and Kinnosuke Yahiro, and Masatoshi Noda
February 2015, Journal of clinical microbiology,
Copied contents to your clipboard!